DevCo Appoints Matias Karioja as Partner

4 November 2024, Helsinki, Finland – DevCo Partners has appointed Matias Karioja as Partner, effective 4 November 2024. Matias has been an instrumental member of DevCo’s investment team since 2017 when he joined the firm from Citigroup. During his time at DevCo, Matias has been closely involved in two DevCo platform investments, eight add-on acquisitions and the recent strategic capital raise for Medix Biochemica. In addition, he has served as the CFO of Medix Biochemica in 2018 – 2020 and actively supported the company’s growth journey as a board member since 2021.

"We are thrilled about the partner appointment of Matias who has significantly contributed to the success of DevCo and our companies by demonstrating exceptional drive and commitment to our mission and values. This expansion of DevCo’s partner group also reflects our ambitious growth plans to further strengthen DevCo’s position as a global leader in long-term single asset funds focusing on high-quality medium-sized companies in fundamentally attractive niche markets”.

Teemu Alahuhta, Partner at DevCo Partners.

DevCo in brief
DevCo is a long-term oriented active owner and development partner dedicated to building world-leading companies in selected niche markets. DevCo provides its companies with hands-on operational resources, strategic support, and significant financial resources to support step changes in their performance. DevCo is currently a significant owner of three global niche leaders, Vexve, Medix Biochemica, and Bluefors.

‍